| Title |
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
|
|---|---|
| Published in |
Trials, June 2020
|
| DOI | 10.1186/s13063-020-04421-z |
| Pubmed ID | |
| Authors |
Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, Gemma Moncunill, Aina Casellas, Francisco Carmona-Torre, Miriam Giráldez, Juana Schwartz Mota, José Ramón Yuste, José Ramón Azanza, Miriam Fernández, Gabriel Reina, Carlota Dobaño, Joe Brew, Belen Sadaba, Felix Hammann, Regina Rabinovich |
X Demographics
The data shown below were collected from the profiles of 179 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 41 | 23% |
| Turkey | 7 | 4% |
| Spain | 6 | 3% |
| Brazil | 2 | 1% |
| Sao Tome and Principe | 2 | 1% |
| United Kingdom | 2 | 1% |
| Belgium | 1 | <1% |
| Germany | 1 | <1% |
| Australia | 1 | <1% |
| Other | 4 | 2% |
| Unknown | 112 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 174 | 97% |
| Practitioners (doctors, other healthcare professionals) | 3 | 2% |
| Scientists | 2 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 742 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 742 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 94 | 13% |
| Student > Master | 92 | 12% |
| Researcher | 72 | 10% |
| Other | 46 | 6% |
| Student > Ph. D. Student | 37 | 5% |
| Other | 134 | 18% |
| Unknown | 267 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 206 | 28% |
| Nursing and Health Professions | 64 | 9% |
| Biochemistry, Genetics and Molecular Biology | 26 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 3% |
| Social Sciences | 18 | 2% |
| Other | 106 | 14% |
| Unknown | 301 | 41% |